Daklinza: Medgend

Daklinza FDA Approved Drugs

DAKLINZA [Daclatasvir Dihydrochloride^{C₄₀H₅₀N₈O₆2ClH}]

eq 30mg base (oral tablet)

eq 60mg base (oral tablet)

eq 90mg base (oral tablet)

Bristol-myers Squibb^{Jul 24, 2015}

Method of inhibiting hepatitis c virus with daklinza and at least one additional compound having anti-hcv activity.
Method of inhibiting hepatitis c virus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.